。 本次“賣身”天士力,在外界看來或許與天士力集團生物醫(yī)藥業(yè)務調(diào)整有關。2020年和2023年,天士力就已相繼出售天士力營銷和天士力醫(yī)藥商業(yè)部分資產(chǎn)。2022年,天士力計劃分拆上市的創(chuàng)新藥公司天士力生物
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net profit of 1 billion
熱評:
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net profit of 686.8
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net profit of 262.7
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net loss of 340.8
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net loss of 410.2
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net loss of 463.5
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net loss of 595.3
圖片
視頻
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net profit of 1 billion
熱評:
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net profit of 1 billion
熱評:
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net profit of 686.8
熱評:
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net profit of 262.7
熱評:
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net loss of 340.8
熱評:
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net loss of 410.2
熱評:
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net loss of 463.5
熱評:
Tasly Pharmaceutical Group Co.,Ltd. (天士力醫(yī)藥集團股份有限公司) (600535.SH) reported a net loss of 595.3
熱評: